SANKYO C22 (Benicar HCT 12.5 mg / 20 mg)

Generic Name: hydrochlorothiazide/olmesartan

Pill imprint SANKYO C22 has been identified as Benicar HCT 12.5 mg / 20 mg.

Benicar HCT is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Benicar HCT 12.5 mg / 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for SANKYO C22

Benicar HCT 12.5 mg / 20 mg SANKYO C22
Benicar HCT 12.5 mg / 20 mg SANKYO C22
Benicar HCT 12.5 mg / 20 mg SANKYO C22
Benicar HCT
Generic Name:
hydrochlorothiazide/olmesartan
Imprint:
SANKYO
C22
Strength:
12.5 mg / 20 mg
Color:
Yellow
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sankyo Pharma
National Drug Code (NDC):
65597-0105
Inactive Ingredients:
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
low substituted hydroxypropyl cellulose
magnesium stearate
microcrystalline cellulose
ferric oxide red
magnesium silicate
titanium dioxide
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5170 Physicians Total Care Inc (repackager)
35356-0256 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)